证券研究报告 非银金融 | 保险Ⅱ 港股|首次覆盖报告 hyzqdatemark 2026 年 02 月 26 日 证券分析师 陆韵婷 SAC：S1350525050002 luyunting@huayuanstock.com 沈晨 SAC：S1350525090002 shenchen@huayuanstock.com 市场表现： | 基本数据 | 2026 | 年 | 02 月 日 | 23 | | | --- | --- | --- | --- | --- | --- | | 收盘价（港元） | | | | | 34.58 | | 一年内最高/最低（港 | | | 36.16/12.38 | | | | 元） | | | | | | | 总市值（百万港元） | | | | 977,393.50 | | | 流通市值（百万港元） | | | | 257,315.83 | | | 资产负债率（%） | | | | | 91.39 | | 资料来源：聚源数据 | | | | | | 中国人寿(02628.HK) 联系人 点评： 1、从财务指标来看： 3、投资业务：投资收益率同比提升 104bp A、 中国人寿 ...

Investment Rating - The report assigns an "Accumulate" rating to the company [1][6]. Core Insights - The report highlights the strong innovation and R&D capabilities of the company, which is entering a harvest period for innovative drugs and has established an international business development ecosystem with several significant licensing agreements [2][10]. - The company is expected to achieve a significant increase in EPS from 0.37 in 2024 to 0.75 in 2025, with a projected growth rate of 48% [10]. - The target price for the company is set at 16.58 HKD, reflecting a favorable valuation based on comparable company analysis [10]. Financial Summary - Total revenue is projected to be 31,450.11 million RMB in 2023, with a slight increase of 1.7% [4]. - Net profit is expected to decrease by 3.6% in 2023, followed by a significant recovery of 47.5% in 2025 [4]. - The company’s PE ratio is forecasted to decrease from 18.26 in 2023 to 12.34 in 2026, indicating an improving valuation over time [4]. Pipeline Overview - The company has a leading position in the oncology pipeline, particularly with SYS6010, which is the fastest progressing EGFR ADC globally, with multiple early-stage assets expected to report data in 2026 [10][16]. - In the weight loss and metabolic areas, the company has established a leading position domestically and has signed a strategic collaboration with AstraZeneca for the development of innovative long-acting peptide drugs [10][24]. - The company has a robust pipeline in the small nucleic acid technology sector, positioning it as a leader in the domestic siRNA market [10][24]. Business Development and International Strategy - The company is making steady progress in its international strategy, with ongoing collaborations with AstraZeneca and other multinational corporations, reflecting its competitive edge in innovative drug development [10][24]. - The company is expected to continue achieving external licensing agreements, with over 20 innovative drug assets entering clinical stages annually [10][24].

個股推介 心動公司(2400.HK) 2026 年 2 月 26 日星期四 《心動小鎮》國際版 1 月上線，下載量及流水表現亮眼 集團自研的生活模擬遊戲《心動小鎮》於 1 月 8 日上線國際版。根據 AppMagic 發布的 1 月全球手遊下載排行榜，《心動小鎮》首次入榜即 位列第 11 位，全球下載量超 1,200 萬，主要來自美國、日本、韓國、 泰國等。《心動小鎮》國際服(包括 AppStore 及 GooglePlay)1 月的預 估流水達 6,000 萬元人民幣，而 TapTap 的流水尚未計算在內。從地區 收入佔比来看，日本最高，其次為韓國及美國。數據顯示《心動小鎮》 市場接受度高，為未來長期營運及 2026 年業績增長奠定基礎。 穩定的存量遊戲及潛力新作，有望推動業績持續增長 集團 2025 年上半年業績勝預期，收入按年增長 39%至 30.8 億元人民 幣，經調整溢利增長 206%至 8.5 億元人民幣，分別較市場預測高 14% 及 74%，主要由於遊戲及 TapTap 平台增長超預期。集團擁有多個長 青遊戲產品，包括《仙境傳說 M：初心服》、《心動小鎮》、《火炬之 光：無限》等，用戶基礎穩定， ...

息差回升及财富优异推动盈利向好 | 华泰研究 | | | 年报点评 | 投资评级(维持): | 买入 | | --- | --- | --- | --- | --- | --- | | 2026 年 | 2 月 | 25 日│中国香港 | 区域性银行 | 目标价(港币): | 166.07 | 经调口径下，汇丰控股 25A 营收同比+5.1%，税前利润同比+7.1%，增速较 25Q1-3 分别+0.3pct、+2.6pct。2025 年经调 ROTE 为 17.2%，同比 2024 年+1.6pct，主因净利息收入增长及财富管理收入增加。董事会已通过派发 第四次股息每股0.45美元，2025年每股合计派息0.75美元。公司指引2026、 2027 及 2028 年平均 ROTE 达到 17%甚至更高，争取 28 年营收同比增速 达 5%。鉴于公司组织架构调整提升运营效率，维持"买入"评级。 证券研究报告 NII 环比提升，指引 26 年最少达 450 亿美元 汇丰控股 (5 HK) 港股通 公司 2025 年银行业务净利息收益同比+0.2%至 441 亿美元，其中 25Q4 单 季环比 Q3+6.1%，主要受 ...

证券研究报告 京东工业 (7618 HK) 专注于供应链数字化领域的创新者 2026 年 2 月 25 日│中国香港 首次覆盖京东工业，给予"买入"评级，目标价 18.47 港元，对应 2026 年 目标调整后净利润 PE 28x。2024 年以 GMV 计，公司为中国最大的工业供 应链技术与服务提供商。以"太璞"数字化工业供应链整体解决方案为基， 公司已建立覆盖全流程端到端供应链数字基础设施。我们看好公司在工业采 购数字化和线上化率提升的行业大背景下，利用自身技术驱动的效率提升能 力和集团协同效应，持续深化核心用户规模和份额增长，并通过切入 BOM、 国际业务和自有品牌等举措，实现中长期收入规模和利润率双重扩张。 工业供应链数字化和透明化或为大势所趋 中国工业供应链市场规模庞大，2024 年达 11.4 万亿，但结构高度分散且长 期依赖线下多层级的传统体系，存在成本高、效率低、透明度不足的痛点。 供给侧，随着基础升级和技术的逐步成熟，工业供应链正加速向数字化和一 体化方向演进。政策上，阳光采购、合规监管与财税规范化要求进一步强化 了企业对可追溯、可管理供应链解决方案的需求。市场空间上，工业供应链 技术与服务 ...

26 Feb 2026 CMB International Global Markets | Equity Research | Company Update Yancoal Australia (3668 HK) Yancoal Australia (3668 HK) - 2026 earnings 2025 profit below consensus; resilient coal price to support 2026 earnings Yancoal's (YAL) net profit in 2025 came in at A$440mn (-64% YoY), which is 15% below Bloomberg consensus but 20% above our estimates due to the high earnings sensitivity to the unit cash margin. YAL declared a final dividend of A$0.122/shr. This, together with the interim dividend of ...

Investment Rating - The report maintains a "BUY" rating for FIT Hon Teng, with a target price raised to HK$7.33, indicating a potential upside of 22% from the current price of HK$6.01 [3][22]. Core Insights - FIT Hon Teng is positioned to benefit from significant growth drivers, particularly in AI-related revenue, which is expected to grow at a 95% CAGR from FY25 to FY27, reaching 18% of total revenue by FY27, up from 6% in FY25 [1][9]. - The company is anticipated to experience revenue and net profit growth of 11% YoY for FY25, with a notable increase in net profit growth of 21% YoY in 4Q25 [1][9]. - Upcoming catalysts include major industry events such as GTC and OFC 2026, which are expected to focus on advancements in interconnect and CPO solutions [1][22]. Financial Summary - Revenue is projected to increase from US$4,196 million in FY23 to US$6,696 million by FY27, reflecting a compound annual growth rate (CAGR) of 19.2% [2][24]. - Net profit is expected to rise from US$129.6 million in FY23 to US$434.8 million in FY27, with a significant growth rate of 39.5% in FY27 [2][24]. - The company's P/E ratio is forecasted to decrease from 42.2x in FY23 to 12.6x in FY27, indicating a potential re-rating as AI revenue contributions increase [2][22]. Segment Performance - The revenue breakdown indicates strong growth in the networking segment, with a projected increase of 56% YoY by FY27, while the smartphone segment is expected to decline by 16% in FY25 [19][24]. - AI server revenue is anticipated to grow significantly, reaching US$1.23 billion by FY26, contributing to the overall revenue mix [19][24]. - The mobility segment is also expected to show robust growth, with a projected increase of 95% YoY in FY25 [19][24].

风险提示：行业竞争加剧；成长异常上行；食品安全风险 管理焕新，否极泰来可期 华润饮料(2460) 华润饮料（2460）更新报告 | 财务摘要(百万人民币) | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入 | 13,515 | 13,521 | 11,104 | 12,465 | 13,945 | | (+/-)% | 7.1% | 0.0% | -18% | 12% | 12% | | 毛利润 | 6,035 | 6,397 | 5,067 | 5,785 | 6,520 | | 净利润 | 1,329 | 1,637 | 956 | 1,211 | 1,489 | | (+/-)% | 34.3% | 23.1% | -42% | 27% | 23% | | PE | - | 13.08 | 23.11 | 18.25 | 14.84 | | PB | - | 2.19 | 1.86 | 1.70 | 1.53 | | 资料来源：Wind，国泰海通证券研究 | | | | | | ...

Investment Rating - The report assigns a "Buy" rating for Hong Kong Exchanges and Clearing Limited (00388.HK) as a first coverage [4]. Core Insights - The report highlights that Hong Kong Exchanges and Clearing Limited experienced a significant increase in revenue and net profit for the first three quarters of 2025, with revenue and net profit growing by 37% and 45% year-on-year, reaching HKD 21.9 billion and HKD 13.4 billion respectively [4]. - The EBITDA margin improved by 5 percentage points to 79% due to scale effects, with Q3 alone showing an 8% and 10% quarter-on-quarter growth in revenue and net profit [4]. - The report emphasizes the strong performance in spot trading and stock options, with average daily trading amounts (ADT) for stock securities products increasing by 150% year-on-year to HKD 267.9 billion in Q3 [5]. Summary by Sections Financial Performance - For the first three quarters of 2025, the revenue from spot trading increased by 75% year-on-year to HKD 111 billion, accounting for 51% of total revenue [5]. - The average daily trading amount for southbound and northbound trading increased by 285% and 144% respectively, contributing to the overall growth in trading volume [5]. - The financial derivatives segment saw a decline in average daily contract volume by 7% year-on-year, while stock options trading increased by 30% [5]. Strategic Initiatives - Hong Kong Exchanges and Clearing Limited has implemented several strategic measures, including the launch of LME-approved warehousing facilities and adjustments to minimum price fluctuations in the securities market [6][7]. - The company is also focusing on enhancing market vitality and technological empowerment, with plans to shorten the settlement cycle for the cash market [6][7]. IPO Contributions - In the first three quarters of 2025, there were 69 successful IPOs on the Hong Kong Exchange, raising a total of HKD 188.3 billion, marking the highest level since 2022 [8]. - The report notes that internet and technology stocks were the main contributors to trading volume, with the top ten stocks accounting for 30% of the total market ADT [8]. Profit Forecast and Valuation - The report projects that the net profit for Hong Kong Exchanges and Clearing Limited will reach HKD 17.9 billion, HKD 20.3 billion, and HKD 22.1 billion for 2025, 2026, and 2027 respectively, with year-on-year growth rates of 37.5%, 13.1%, and 9.0% [9]. - The current price-to-earnings (P/E) ratios are forecasted to be 29.1, 25.7, and 23.6 for the years 2025, 2026, and 2027 [9].

率优化共振 [Table_Page] 公告点评|消费者服务Ⅱ 证券研究报告 [Table_Title] 【广发批零社服&海外】绿茶集团 （06831.HK） 25 年经调净利同增 33%-47%，开店+同店+利润 [Table_PicQuote] 相对市场表现 核心观点：（汇率采用 1 港元=0.8877 人民币） 盈利预测：（除非特别注明，本文货币为人民币） | [Table_ 单位 Finance] :人民币百万元 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 主营收入 | 3,589 | 3,838 | 4,758 | 5,991 | 7,368 | | 增长率（%） | 51.1% | 6.9% | 24.0% | 25.9% | 23.0% | | EBITDA | 799 | 884 | 1,080 | 1,244 | 1,446 | | 归母净利润 | 296 | 350 | 494 | 619 | 777 | | 增长率（%） | - | 18.5% | 41.0% | 25. ...